| pubmed-article:15764753 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15764753 | lifeskim:mentions | umls-concept:C0242510 | lld:lifeskim |
| pubmed-article:15764753 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:15764753 | lifeskim:mentions | umls-concept:C0920317 | lld:lifeskim |
| pubmed-article:15764753 | lifeskim:mentions | umls-concept:C0003211 | lld:lifeskim |
| pubmed-article:15764753 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:15764753 | pubmed:dateCreated | 2005-3-14 | lld:pubmed |
| pubmed-article:15764753 | pubmed:abstractText | Studies done both in laboratory animals and humans suggest that nonsteroidal antiinflammatory drug (NSAID) use may reduce the risk of developing lung cancer. Many epidemiologic studies exploring this association lacked sufficient power to draw definitive conclusions. We conducted a metaanalysis to examine the effect of NSAID use on the risk of lung cancer. | lld:pubmed |
| pubmed-article:15764753 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15764753 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15764753 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15764753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15764753 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15764753 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:15764753 | pubmed:issn | 0012-3692 | lld:pubmed |
| pubmed-article:15764753 | pubmed:author | pubmed-author:KhuderSadik... | lld:pubmed |
| pubmed-article:15764753 | pubmed:author | pubmed-author:HerialNabeel... | lld:pubmed |
| pubmed-article:15764753 | pubmed:author | pubmed-author:MutgiAnand... | lld:pubmed |
| pubmed-article:15764753 | pubmed:author | pubmed-author:FedermanDougl... | lld:pubmed |
| pubmed-article:15764753 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15764753 | pubmed:volume | 127 | lld:pubmed |
| pubmed-article:15764753 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15764753 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15764753 | pubmed:pagination | 748-54 | lld:pubmed |
| pubmed-article:15764753 | pubmed:meshHeading | pubmed-meshheading:15764753... | lld:pubmed |
| pubmed-article:15764753 | pubmed:meshHeading | pubmed-meshheading:15764753... | lld:pubmed |
| pubmed-article:15764753 | pubmed:meshHeading | pubmed-meshheading:15764753... | lld:pubmed |
| pubmed-article:15764753 | pubmed:meshHeading | pubmed-meshheading:15764753... | lld:pubmed |
| pubmed-article:15764753 | pubmed:meshHeading | pubmed-meshheading:15764753... | lld:pubmed |
| pubmed-article:15764753 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15764753 | pubmed:articleTitle | Nonsteroidal antiinflammatory drug use and lung cancer: a metaanalysis. | lld:pubmed |
| pubmed-article:15764753 | pubmed:affiliation | Department of Medicine, Medical College of Ohio, 3120 Glendale Ave, Toledo, OH 43614-5809. skhuder@mco.edu. | lld:pubmed |
| pubmed-article:15764753 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15764753 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15764753 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15764753 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15764753 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15764753 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15764753 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15764753 | lld:pubmed |
